Read label instructions and precautionary statements
prior to use.
The susceptibility of the bacterial present should
be determined before use.
Use exactly as prescribed.
- Reconstitute with 10 mL sterile water for injection.
- Shake well and let vial sit until all material is
- Sterilize the site of injection and the syringe.
- Administer via subcutaneous injection.
- Dose Convenia at 3.6 mg per pound of body weight.
- Return vial to the original container and the refrigerator
right away when unused product remains.
- Give dogs a second dose when needed.
Dose Table for CONVENIA at 8 mg/kg Body Weight.
Weight of Animal
Volume of CONVENIA (3.6 mg/lb or 0.045 mL/lb)
Frequency of Use:
Convenia is usually given once. Therapeutic concentrations
are maintained in cats for 7 days with Pasteurella multocida infections. In dogs, therapeutic concentrations
are maintained for 7 days with Staphylococcus intermedius infections and for 14 days with Streptococcus canis infections. Dogs may receive a second dose when
needed. Do not exceed 1 dose in cats or 2 doses in dogs.
Keep Convenia in its original container, out of reach
of children and animals.
Store powdered and reconstituted forms in the refrigerator,
between 36 and 46 degrees F. Convenia is light sensitive.
Use or discard reconstituted product within 28 days.
It is a violation of Federal
Law to use this product in a manner inconsistent with its labeling.
Convenia Ingredients (per mL reconstituted): cefovecin sodium equivalent to 80 mg cefovecin,
methylparaben (preservative) 1.8 mg, propylparaben (preservative) 0.2
mg, sodium citrate dihydrate 5.8 mg, citric acid monohydrate 0.1 mg,
sodium hydroxide or hydrochloric acid as required to adjust pH
Keep this product out of reach of children and animals.
Do not use or store in or near open flame or heat. Convenia is light
sensitive. Keep refrigerated.
The color may vary from clear to amber and become
darker over time. When properly stored, the product's color is not
an indication of potency.
Convenia is only intended for use in cats and dogs.
Do not administer to other species. Do not use in any animal for which
it was not prescribed. Not for use in humans.
For subcutaneous injection only.
Follow the specifications of the prescription.
CAUTION: The susceptibility of the infection
should be determined prior to use. Use with non-susceptible organisms
will not provide benefit and increases the risk of antibiotic-resistant
If no improvement is seen within 3 to 4 days, contact
your veterinarian for reconsideration of the diagnosis and treatment
Do not exceed one dose in cats and two doses in dogs.
Not for use in animals with an allergy to cefovecin,
other cephalosporins, or penicillins. Anaphylaxis may occur and requires
emergency veterinary treatment, possibly including epinephrine, oxygen,
corticosteroids, intravenous fluids or antihistamines, airway management,
or other therapies.
Consult your physician or a poison control center
in the event of human exposure. Convenia may trigger allergic reactions
in susceptible human individuals during handling. Such individuals should
avoid contact with the skin and mucous membranes.
The safety of Convenia in animals younger than 4
months of age and in lactating and breeding animals has not been proven.
The long-term effects at the site of injection have
not been determined.
It takes up to 65 days for 97% of this medication
to be eliminated from the system. Animals experiencing adverse effects
should be monitored for the duration of this period.
Side effects may include irritation at the site of
injection, diarrhea, emesis, diminished appetite, and lethargy. Additional
side effects in dogs may include bloody stool, flatulence, increased
rumbling in the stomach, and dehydration. Additional side effects in
cats may include inappropriate urination, hyperactivity, and strange
behavior. Consult your veterinarian about any adverse reactions that
are particularly bothersome to your pet.
Convenia may interact with NSAIDs, anticonvulsants,
propofol, cardiac medications, behavioral medications, and other drugs
and supplements. Consult your veterinarian before concurrently administering
any other drugs or supplements.
Positive direct Coombs' test results, false positive
reactions for glucose in the urine, and falsely elevated urine protein
determinations have occurred with use of some cephalosporins. These
and other antimicrobials may also cause lowered albumen values.
Cephalosporins have been associated with myelotoxicity,
causing a toxic neutropenia. Other hematological reactions may include
anemia, neutropenia, hypoprothrombinemia, thrombocytopenia, prolonged
prothrombin time and partial thromboplastin time, platelet dysfunction
and temporary increases in serum aminotransferases.
Use or discard the contents of the vial within 28
days of reconstitution.
Warranty and Manufacturer Information:
NADA# 141-285, Approved by FDA
Distributed by: Pfizer Animal Health, Div. of Pfizer
Inc, NY, NY 10017
820 038 000
NAC No.: 36902450